Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

Allers K, Hütter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E, Schneider T.

Blood. 2011 Mar 10;117(10):2791-9. doi: 10.1182/blood-2010-09-309591. Epub 2010 Dec 8.

2.

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E.

N Engl J Med. 2009 Feb 12;360(7):692-8. doi: 10.1056/NEJMoa0802905.

3.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
4.

Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells.

Hütter G, Ganepola S.

ScientificWorldJournal. 2011 May 5;11:1068-76. doi: 10.1100/tsw.2011.102.

5.

Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.

Guadalupe M, Sankaran S, George MD, Reay E, Verhoeven D, Shacklett BL, Flamm J, Wegelin J, Prindiville T, Dandekar S.

J Virol. 2006 Aug;80(16):8236-47.

6.

CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.

Nicholson JK, Browning SW, Hengel RL, Lew E, Gallagher LE, Rimland D, McDougal JS.

J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):105-15.

PMID:
11404531
7.

Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4.

Taub DD, Mikovits JA, Nilsson G, Schaffer EM, Key ML, Petrow-Sadowski C, Ruscetti FW.

Cell Immunol. 2004 Aug;230(2):65-80.

PMID:
15598422
8.

Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection.

Oswald-Richter K, Grill SM, Leelawong M, Tseng M, Kalams SA, Hulgan T, Haas DW, Unutmaz D.

PLoS Pathog. 2007 Apr;3(4):e58.

9.

CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.

Duarte RF, Salgado M, Sánchez-Ortega I, Arnan M, Canals C, Domingo-Domenech E, Fernández-de-Sevilla A, González-Barca E, Morón-López S, Nogues N, Patiño B, Puertas MC, Clotet B, Petz LD, Querol S, Martinez-Picado J.

Lancet HIV. 2015 Jun;2(6):e236-42. doi: 10.1016/S2352-3018(15)00083-1. Epub 2015 May 19.

PMID:
26423196
10.

The mucosal immune system and HIV-1 infection.

Veazey R, Lackner A.

AIDS Rev. 2003 Oct-Dec;5(4):245-52. Review.

PMID:
15012003
11.

Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7.

Monteiro P, Gosselin A, Wacleche VS, El-Far M, Said EA, Kared H, Grandvaux N, Boulassel MR, Routy JP, Ancuta P.

J Immunol. 2011 Apr 15;186(8):4618-30. doi: 10.4049/jimmunol.1004151. Epub 2011 Mar 11.

12.

Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.

Kourtis AP, Ibegbu CC, Theiler R, Xu YX, Bansil P, Jamieson DJ, Lindsay M, Butera S, Duerr A.

J Infect Dis. 2007 Apr 1;195(7):965-72. Epub 2007 Feb 20.

PMID:
17330786
13.

Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.

Chelucci C, Casella I, Federico M, Testa U, Macioce G, Pelosi E, Guerriero R, Mariani G, Giampaolo A, Hassan HJ, Peschle C.

Blood. 1999 Sep 1;94(5):1590-600.

14.

Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.

Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, Zhang Q, Li D, Zhou P, Su L.

J Virol. 2017 Jan 18;91(3). pii: e01389-16. doi: 10.1128/JVI.01389-16. Print 2017 Feb 1.

PMID:
27881659
16.
17.

Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.

Dubey S, Khalid M, Wesley C, Khan SA, Wanchu A, Jameel S.

J Clin Virol. 2008 Sep;43(1):25-31. doi: 10.1016/j.jcv.2008.03.026. Epub 2008 May 6.

PMID:
18462992
18.

T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.

Swan CH, Bühler B, Steinberger P, Tschan MP, Barbas CF 3rd, Torbett BE.

Gene Ther. 2006 Oct;13(20):1480-92. Epub 2006 Jun 1. Erratum in: Gene Ther. 2007 Apr;14(7):626. Steinberger, P [added].

PMID:
16738691
19.
20.

Supplemental Content

Support Center